Merit Medical Systems Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Merit Medical Systems ha aumentado sus beneficios a una tasa media anual de 38.6%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 4.3% anual. Los ingresos han ido creciendo a una tasa media de 6.4% al año. La rentabilidad financiera de Merit Medical Systems es de 7.9%, y sus márgenes netos son de 7.5%.

Información clave

43.5%

Tasa de crecimiento de los beneficios

42.5%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	4.3%
Tasa de crecimiento de los ingresos	6.5%
Rentabilidad financiera	8.2%
Margen neto	7.9%
Última actualización de beneficios	31 Mar 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Merit Medical Systems. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

DB:MM3 Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Mar 24	1,283	102	378	83
31 Dec 23	1,257	94	374	83
30 Sep 23	1,226	100	360	82
30 Jun 23	1,198	90	363	81
31 Mar 23	1,173	85	348	79
31 Dec 22	1,151	75	342	76
30 Sep 22	1,136	62	317	75
30 Jun 22	1,116	58	308	73
31 Mar 22	1,101	48	319	72
31 Dec 21	1,075	48	330	71
30 Sep 21	1,054	43	338	66
30 Jun 21	1,031	28	327	63
31 Mar 21	969	4	293	59
31 Dec 20	964	-10	298	58
30 Sep 20	964	-29	279	59
30 Jun 20	963	-30	296	62
31 Mar 20	1,000	-4	313	64
31 Dec 19	995	5	324	66
30 Sep 19	970	19	307	65
30 Jun 19	949	39	288	62
31 Mar 19	918	43	277	61
31 Dec 18	883	42	262	60
30 Sep 18	840	40	240	57
30 Jun 18	798	19	227	55
31 Mar 18	760	18	215	53
31 Dec 17	728	28	210	51
30 Sep 17	695	28	201	50
30 Jun 17	672	33	199	49
31 Mar 17	637	31	186	47
31 Dec 16	604	20	183	45
30 Sep 16	580	19	179	45
30 Jun 16	559	23	166	44
31 Mar 16	546	23	161	42
31 Dec 15	542	24	156	41
30 Sep 15	537	26	152	39
30 Jun 15	529	29	149	37
31 Mar 15	520	25	148	38
31 Dec 14	510	23	148	37
30 Sep 14	497	21	143	36
30 Jun 14	483	19	138	35
31 Mar 14	464	19	132	34
31 Dec 13	449	17	127	34
30 Sep 13	431	11	126	33
30 Jun 13	412	12	123	33

Ingresos de calidad: MM3 tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (7.5%) de MM3 son superiores a los del año pasado (6.5%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lMM3 han crecido significativamente en un 38.6% al año.

Acelerando crecimiento: El crecimiento de los beneficios de MM3 en el último año (26.7%) está por debajo de su media de 5 años (38.6% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de MM3 en el último año (20.4%) superó al de la industria Medical Equipment -6.1%.

Merit Medical Systems Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings released: EPS: US$0.49 (vs US$0.36 in 1Q 2023)

Merit Medical Systems, Inc. to Report Q1, 2024 Results on Apr 30, 2024

Full year 2023 earnings released: EPS: US$1.64 (vs US$1.31 in FY 2022)

Merit Medical Systems, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Third quarter 2023 earnings released: EPS: US$0.45 (vs US$0.27 in 3Q 2022)

Merit Medical Systems, Inc. to Report Q3, 2023 Results on Oct 26, 2023

Recent updates

Merit Medical Elects Silvia M. Perez as New Director

Merit Medical Systems, Inc. Announces Appointment of Joe Wright as President

Merit Medical Systems, Inc. Announce US Food and Drug Administration (FDA) 510(K) Clearance for its Siege Vascular Plug and Launches its Bearing nsPVA Express Prefilled Syringe in the United States and Australia

Merit Medical Systems, Inc. Reaffirms Sales Guidance for the Year Ending December 31, 2024

First quarter 2024 earnings released: EPS: US$0.49 (vs US$0.36 in 1Q 2023)

Merit Medical Systems, Inc., Annual General Meeting, May 15, 2024

Merit Medical Systems, Inc. Launches the Micro Ace Advanced Micro-Access System

Merit Medical Systems, Inc. to Report Q1, 2024 Results on Apr 30, 2024

CFO & Treasurer recently sold €439k worth of stock

Merit Medical Systems, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024

Full year 2023 earnings released: EPS: US$1.64 (vs US$1.31 in FY 2022)

Now 20% overvalued after recent price rise

Merit Medical Systems, Inc. Receives FDA 510(K) Clearance for Scout MD Surgical Guidance System

Now 21% overvalued after recent price rise

Merit Medical Systems, Inc. Enrolls First Patient in Merit Medical’s MOTION Study

Merit Medical Systems, Inc. Provides Revenue Guidance for the Year 2023

Merit Medical Systems, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Merit Medical Systems, Inc. Revises Earnings Guidance for the Fiscal Year Ended December 31, 2023

Third quarter 2023 earnings released: EPS: US$0.45 (vs US$0.27 in 3Q 2022)

Now 22% undervalued after recent price drop

Merit Medical Launches Expanded Maestro Microcatheter Line

Merit Medical Systems, Inc. to Report Q3, 2023 Results on Oct 26, 2023

Merit Medical Launches the Aspira® Evacuated Drainage Bottle

Now 21% undervalued after recent price drop

Merit Medical Systems, Inc. Announces Completion of Enrollment in Its Wawsody Arteriovenous Access Efficacy Pivotal Study

Merit Medical Systems, Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Second quarter 2023 earnings released: EPS: US$0.35 (vs US$0.27 in 2Q 2022)

Merit Medical Systems, Inc. to Report Q2, 2023 Results on Jul 25, 2023

Merit Medical Systems, Inc.(NasdaqGS:MMSI) dropped from Russell Small Cap Comp Value Index

Merit Medical Systems, Inc. (NasdaqGS:MMSI) acquired Dialysis Product Portfolio and BioSentry Product of AngioDynamics, Inc. (NasdaqGS:ANGO) for $100 million.

First quarter 2023 earnings released: EPS: US$0.36 (vs US$0.19 in 1Q 2022)

Independent Director recently sold €605k worth of stock

Founder recently sold €1.4m worth of stock

Full year 2022 earnings released: EPS: US$1.31 (vs US$0.86 in FY 2021)

Merit Medical Receives FDA Breakthrough Device Designation for the New SCOUT® MD™ Surgical Guidance System

Merit Medical Systems, Inc. to Report Q4, 2022 Results on Feb 22, 2023

First Patient Enrolled in Merit Medical Systems, Inc.'s Multicenter Observational Study to Evaluate the Use of Embocube(R) Embolization Gelatin to Control Bleeding or Hemorrhage

Merit Medical Launches the basixALPHA Inflation Device

Merit Medical Launches the PreludeSYNC EZ™ Radial Compression Device

High number of new directors

Merit Medical Systems, Inc. Appoints Joe Wright to Chief Commercial Officer

Third quarter 2022 earnings released: EPS: US$0.27 (vs US$0.21 in 3Q 2021)

Merit Medical Systems, Inc. Revises Earnings Guidance for Year Ending December 31, 2022

Merit Medical Systems, Inc. to Report Q3, 2022 Results on Oct 26, 2022

Merit Medical Launches the Temno Elite™ Soft Tissue Biopsy System

Merit Medical Systems, Inc. Launches the Prelude Roadster Guide Sheath

Insider recently sold €1.6m worth of stock

Merit Medical Systems, Inc. Launches SafeGuard Focus Cool™ Compression Device

Second quarter 2022 earnings released: EPS: US$0.27 (vs US$0.088 in 2Q 2021)

Merit Medical Systems, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2022

Merit Medical Systems, Inc. Launches Smallest and Shortest Configuration of Elation® Pulmonary Balloon Dilator to Help Meet Critical Patient Need

Merit Medical Systems, Inc. to Report Q2, 2022 Results on Jul 27, 2022

Merit Medical Systems, Inc. Announces First Patient Enrolled in the Streamlined Localization (STREAMLoc) Registry Study Using SCOUT(R) at Biopsy in Canada

Merit Medical Systems, Inc. Announces Launch of the Scout Mini Reflector

Merit Medical Systems, Inc. Announces the Successful Enrollment of the First Patient in Its Wrap Registry Study

First quarter 2022 earnings released: EPS: US$0.19 (vs US$0.20 in 1Q 2021)

High number of new directors

Merit Medical Systems, Inc. Announces Executive Changes

Merit Medical Systems, Inc. Launches Resolve® Thoracostomy Tray

Merit Medical Systems, Inc. to Report Q1, 2022 Results on Apr 27, 2022

Merit Medical Systems, Inc. Receives FDA Clearance for SCOUT Bx™ Delivery System

PE Firms Reportedly Show Interest in Deal for Merit Medical

Merit Medical Systems, Inc., Annual General Meeting, May 19, 2022

Merit Medical Systems, Inc. Receives FDA Breakthrough Device Designation for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Merit Medical Systems, Inc. Announces Earning Guidance for Year 2022

Saxena White P.A. and Bernstein Litowitz Berger & Grossmann LLP Announce A Proposed Settlement in the Merit Medical Systems, Inc. Securities Litigation

Merit Medical Systems, Inc. Revises Earnings Guidance for the Year Ending December 31, 2021

Third quarter 2021 earnings released: EPS US$0.21 (vs US$0.054 loss in 3Q 2020)

Desglose de ingresos y gastos
Beta